These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 21944974)
21. Organ distribution of mutant mitochondrial tRNA(leu(UUR)) gene in a MELAS patient. Hamazaki S; Koshiba M; Sugiyama T Acta Pathol Jpn; 1993 Apr; 43(4):187-91. PubMed ID: 8493868 [TBL] [Abstract][Full Text] [Related]
22. Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene. Koga Y; Davidson M; Schon EA; King MP Muscle Nerve Suppl; 1995; 3():S119-23. PubMed ID: 7603512 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial DNA mutations at nucleotide positions 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a comparative study. Sakuta R; Goto Y; Horai S; Nonaka I J Neurol Sci; 1993 Apr; 115(2):158-60. PubMed ID: 8482977 [TBL] [Abstract][Full Text] [Related]
24. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes]. Sudo A; Sano H; Kawamura N No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430 [TBL] [Abstract][Full Text] [Related]
25. Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. Rikimaru M; Ohsawa Y; Wolf AM; Nishimaki K; Ichimiya H; Kamimura N; Nishimatsu S; Ohta S; Sunada Y Intern Med; 2012; 51(24):3351-7. PubMed ID: 23257519 [TBL] [Abstract][Full Text] [Related]
26. The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome. Meseguer S; Martínez-Zamora A; García-Arumí E; Andreu AL; Armengod ME Hum Mol Genet; 2015 Jan; 24(1):167-84. PubMed ID: 25149473 [TBL] [Abstract][Full Text] [Related]
27. MELAS and L-arginine therapy. Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739 [TBL] [Abstract][Full Text] [Related]
28. Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. Hayashi J; Ohta S; Takai D; Miyabayashi S; Sakuta R; Goto Y; Nonaka I Biochem Biophys Res Commun; 1993 Dec; 197(3):1049-55. PubMed ID: 8280119 [TBL] [Abstract][Full Text] [Related]
29. [MELAS (mitochondrial myopathy, encephalopathy lactic acidosis, and stroke-like episodes): clinical features and mitochondrial DNA mutations]. Goto Y Nihon Rinsho; 1993 Sep; 51(9):2373-8. PubMed ID: 8411715 [TBL] [Abstract][Full Text] [Related]
30. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961 [TBL] [Abstract][Full Text] [Related]
31. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600 [TBL] [Abstract][Full Text] [Related]
32. Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation. Felk S; Ohrt S; Kussmaul L; Storch A; Gillardon F J Neurol Sci; 2010 Aug; 295(1-2):46-52. PubMed ID: 20570288 [TBL] [Abstract][Full Text] [Related]
33. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS. Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605 [TBL] [Abstract][Full Text] [Related]
34. An 80-year-old mitochondrial disease patient with A3243G tRNA(Leu(UUR)) gene presenting cardiac dysfunction as the main symptom. Higashikata T; Koyama J; Shimada H; Yazaki M; Owa M; Ikeda S Intern Med; 2001 May; 40(5):405-8. PubMed ID: 11393411 [TBL] [Abstract][Full Text] [Related]
35. Mitochondrial DNA and RNA processing in MELAS. Kaufmann P; Koga Y; Shanske S; Hirano M; DiMauro S; King MP; Schon EA Ann Neurol; 1996 Aug; 40(2):172-80. PubMed ID: 8773598 [TBL] [Abstract][Full Text] [Related]
36. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. Ohsawa Y; Hagiwara H; Nishimatsu SI; Hirakawa A; Kamimura N; Ohtsubo H; Fukai Y; Murakami T; Koga Y; Goto YI; Ohta S; Sunada Y; J Neurol Neurosurg Psychiatry; 2019 May; 90(5):529-536. PubMed ID: 29666206 [TBL] [Abstract][Full Text] [Related]
37. A novel tRNA(Val) mitochondrial DNA mutation causing MELAS. Tanji K; Kaufmann P; Naini AB; Lu J; Parsons TC; Wang D; Willey JZ; Shanske S; Hirano M; Bonilla E; Khandji A; Dimauro S; Rowland LP J Neurol Sci; 2008 Jul; 270(1-2):23-7. PubMed ID: 18314141 [TBL] [Abstract][Full Text] [Related]
38. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Santa KM Pharmacotherapy; 2010 Nov; 30(11):1179-96. PubMed ID: 20973690 [TBL] [Abstract][Full Text] [Related]
39. Beneficial effect of L-arginine for stroke-like episode in MELAS. Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086 [TBL] [Abstract][Full Text] [Related]
40. Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS. Koga Y; Davidson M; Schon EA; King MP Nucleic Acids Res; 1993 Feb; 21(3):657-62. PubMed ID: 7680123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]